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Abstract
BACKGROUND: Bone scan is a sensitive but not specific 
method for evaluation of bone metastases. However, the clinical 
data and the pattern of bone scan findings help the physician 
to narrow the diagnostic differentials. We tried to investigate 
the distribution of bone metastases in common cancers using 
bone scintigraphy.
MATERIAL AND METHODS: 160 consecutive patients with 
malignancy (prostate cancer: 32, breast cancer: 107, lung can-
cer: 8, and gastrointestinal cancers: 13) underwent bone scan. 
RESULTS: From the 160 patients, 58 patients (36.3%) had 
abnormal bone scans attributable to metastatic tumor. Bone 
metastases were found in 32.7%, 40.6%, 38.5% and 62.5% of 
patients with breast, prostate, GI and lung cancers, respectively 
(P = 0.35). The most frequently involved area was the spine, 
followed by ribs and pelvic bones. Spine was the most frequent 
site of bone metastases in breast and GI cancers. Except for 
the spine, common locations of bone metastases from breast 
cancer were ribs and sternum. In prostate cancer, the most 
frequent site were spine and pelvis, with similar incidences. In 
lung cancer, ribs followed by spine were most frequent sites of 
bone metastases. 97 (60.6%) of the cancer patients studied had 
symptoms of bone pain. The highest incidence was associated 
with metastatic lesions in bone scan (P = 0.004). Significant 
correlation between location of bone pain and evidence of bone 
metastasis in the same region was noticed in the pelvis (P = 
0.001), skull (P = 0.04), sternum (P = 0.01), spine (P = 0.003) 
and femur (P < 0.001). 
CONCLUSIONS: Our results indicate that the spine and pelvis 
in prostate carcinoma and the spine, ribs and sternum in breast 
carcinoma as well as ribs and spine in lung cancer are most 
frequently invaded. Bone pain in the skull, sternum, lumbar ver-
tebrae, pelvis and proximal portion of femurs are more important 
to keep in mind for metastatic bone involvement. 
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Background
Common malignant tumors, such as breast, prostate and lung 
cancers, frequently have bone metastasis at presentation or during 
follow-up. Bone metastases are responsible for signiﬁ cant morbidity 
and usually have prognostic impact [1, 2]. The bone scan has high 
sensitivity and the ability to examine the whole skeleton, so it is of 
utmost prognostic signiﬁ cance and still remains the most important 
investigation in the evaluation of bone metastases [1]. Bone scan 
is a sensitive but not speciﬁ c method. However, the clinical data and 
the pattern of bone scan ﬁ ndings help the physician to narrow the 
diagnostic differentials. In the present study, we tried to investigate 
the distribution of bone metastases in breast, prostate, gastrointes-
tinal (GI) and lung cancers using bone scintigraphy and determine 
the relationships of bone scan ﬁ ndings and bone pain symptoms. 
Material and methods
160 consecutive patients (44 males and 116 females; average 
age 55.67 ± 14.08 years; age range 29 to 83 years) with histologi-
cally proved malignant disease (32 prostate, 107 breast, 8 lung 
and 13 gastrointestinal cancers) referred to the Nuclear Medicine 
Department underwent bone scan. Each patient received 20 mCi of 
the Tc99m-MDP intravenously. After an approximately 3 hours, scin-
tigraphy was performed using a dual head gamma camera (E.cam 
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Simens). Whole body scan in anterior and posterior projections and 
in individuals spot views were obtained. All bone scans were 
reviewed by two well-trained nuclear medicine physicians. Bone 
scan results were compared with available radiographs and as-
sessed taking into account all available clinical information; any 
positive ﬁ ndings were considered as metastatic bone disease, 
when they could not be attributed to any other known disorder in 
the patient (such as degenerative changes). In patients for whom 
previous conventional bone scans were available, we compared 
the scan ﬁ ndings with previous bone scan results.
The involved area was divided into ten portions: 1. skull, 2. 
sternum; 3. vertebrae; 4. ribs; 5. pelvic bones, including sacroiliac 
joints and sacrum; 6. humeri; 7. scapulae; 8. femora; 9. tibiae and 
ﬁ bulae; and 10. clavicles. 
Statistical analysis. Initially, frequency of the involvement 
of particular anatomical regions were ranked. Student’s t-test, 
Chi-squared test, Fisher’s exact test and one way ANOVA in 
post-hoc analysis were used for statistical analysis. P < 0.05 
was considered as statistically signiﬁ cant difference. 
Results
Of the 160 patients, 107 patients (66.9%) had breast cancer, 32 
patients (20.0%) had prostate carcinoma, 13 patients (8.1%) had 
gastrointestinal carcinoma and 8 patients (5.0%) had lung cancer. 
Of the 160 patients, 58 patients (36.3%) had abnormal bone 
scans attributable to metastatic tumor. 12 patients (7.5%) had single 
bone metastasis while 10 patients (6.2%) had widespread bone 
metastases throughout the axial skeleton. Mean age of patients with 
and without bone metastasis was 57.21 ± 15.55 and 54.79 ± 13.18, 
respectively (P = 0.32). Bone metastases were found in 32.7%, 
40.6%, 38.5% and 62.5% of patients with breast, prostate, GI and 
lung cancers, respectively (P = 0.35). Table 1 shows the frequency 
of speciﬁ c anatomical regions of bone involvement. Of the 30 pa-
tients with metastases to the spine, 3 had lesions in cervical, 20 in 
thoracic and 23 in lumbar vertebrae, respectively. 
97 patients (60.6%) of the cancer studied had symptoms of 
bone pain. The highest incidence was associated with metastatic 
lesions in bone scan (Table 2) (P = 0.004). We analyzed the cor-
relation between the location of bone pain and evidence of bone 
metastatic lesion in the same area. Signiﬁ cant correlation was found 
for following locations: pelvis (P = 0.001), skull (P = 0.04), sternum 
(P = 0.01), spine (p = 0.003), and femur (P < 0.001). We performed 
more detailed analysis of the recorded data and found that there 
was a correlation between the presence of lumbar pain and lum-
bar vertebral metastatic lesions (P = 0.005), while there was no 
correlation for the cervical and thoracic vertebrae. There was also 
a correlation between presence of pain and metastatic lesion in the 
proximal half of the femur (P < 0.001) while there was no correlation 
for the distal portion of the femur. 
Discussion
Bone is one of the most common locations of distant metas-
tases in malignancy. 
Table 2. Frequency of bone pain and metastatic bone involvement 
No pain Symptom of 
bone pain
Total
No bone metastasis 49 (77.8%) 53 (54.6%) 102 (63.8%)
Evidence of bone 
metastasis
14 (22.2%) 44 (45.4%) 58 (36.2%)
Total 63 (100%) 97 (100%) 160 (100%)
Table 1. Frequency of anatomical distribution of bone metastases in prostate, breast, gastrointestinal (GI) and lung cancers
Anatomical site Total Breast cancer Prostate cancer GI cancer Lung cancer
Spine 30 (18.8%) 18/103 (16.8%) 5/27 (15.6%) 5/13 (38.5%) 2/7 (25%)
Ribs 23 (14.4%) 16/103 (15.0%) 2/27 (6.3%) 2/13 (15.4%) 3/7 (37.5%)
Pelvis 15 (9.4%) 9/103 (8.4%) 5/27 (15.6%) 1/13(7.7%) 0/7
Sternum 12 (7.5%) 12/103 (11.2%) 0/27 (0%) 0/13 0/7
Femur 8 (5.0%) 6/103 (5.6%) 2/27 (6.3%) 0/13 0/7
Scapula 6 (3.8%) 4/103 (3.7%) 2/27 (6.3%) 0/13 0/7
Skull 6 (3.8%) 5/103 (4.7%) 1/27 (3.1%) 0/13 0/7
Humerus 3 (1.9%) 3/103 (2.8%) 0/27 (0%) 0/13 0/7
Clavicle 2 (1.3%) 1/103 (0.9%) 1/27 (3.1%) 0/13 0/7
Tibia and ﬁ bula 1 (0.6%) 0/103 (0%) 1/27 (3.1%) 0/13 0/7
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Bone scintigraphy has been a perfect method for evaluation 
of bone metastasis and cancer staging for several decades and it 
is still a procedure of choice in many of these clinical settings [1–14]. 
In the present study, the incidence of bone metastasis from prostate 
carcinoma (40.6%%) did not differ signiﬁ cantly from that of breast 
carcinoma bone metastasis (32.7%). In agreement to our results, 
Wilson et al. [3] as well as Tofe et al. [4] reported that the difference 
in bone metastasis incidence between breast and prostate carci-
nomas was not signiﬁ cant. Although Tofe et al. reported the higher 
incidences of bone metastasis of breast and prostate cancers (67 
vs. 62%, P = 0.25), Wilson reported similar frequency to our study 
(28% vs. 35%, P = 0.52). Some differences are likely due to the 
different study populations. 
Our study focused on the area most commonly involved in the 
bone metastases. According to our data, the most frequently in-
volved area was the spine, followed by ribs and pelvic bones. Spine 
was most frequent site of bony metastases in breast and GI cancers. 
Except for the spine, common locations of bone metastases from 
breast cancer were the ribs and sternum. In prostate cancer, the 
most frequent sites were spine and pelvis, with similar incidences. 
However, as compared to the breast cancer, the lower incidence of 
involving the ribs and, particularly, the sternum was noticed in the 
prostate cancer. On the other hand, in the lung cancer, ribs followed 
by spine were most frequent sites of bone metastases.
It has been observed that malignant tumors metastasize ac-
cording to predictable patterns. Several theories were proposed 
to explain this tumor behavior [5]. The ‘‘seed and soil’’ theory pro-
posed by Paget was an explanation for the non-random patterns of 
cancer metastases. This theory is still relevant today, although 
different factors involved in the attraction and subsequent growth 
of prostate cancer cells to the bone have been discovered. These 
factors include: accumulation of genetic changes within cancer 
cells, the preferential binding of cancer cells to bone marrow en-
dothelial cells, and the release of cancer cell chemo-attractants from 
bone elements [6].
Other theory proposed by Ewing indicates that metastatic 
deposits were primarily a mechanical phenomenon [5]. Cancer 
cells were directed to a speciﬁ c site based on the anatomy of 
the blood ﬂ ow and lymphatics. It is likely that both of these theo-
ries are correct, at least in part [6]. Indeed, both anatomical com-
ponents (i.e., Batson venous plexus) and site-speciﬁ c molecular 
interactions were responsible for prostate cancer spread to the 
bone [7]. 
In agreement to the seed and soil theory, bone metastases oc-
cur almost exclusively in areas containing active red marrow. Ac-
tive red bone marrow represents an attractive site for metastatic 
involvement because of sinusoidal vascular spaces and relatively 
easy barrier for penetration of tumor cells [5].
We showed that the pelvis and spine are the main predilection 
sites of prostate cancer, rather than the ribs and sternum. Spread-
ing through the Batson venous plexus explained the following hy-
pothesis that prostatic cancer cells are directed into the pelvis and 
spine early in the disease and later metastasize to other parts of 
the skeleton, such as ribs [3].
However, in breast cancer rib metastases were more frequent 
than in prostate cancer. It’s may be due to different spreading 
pathways. At early stage, breast cancer may directly invade the 
nearby ribs or may also spread to the ribs via the aorta following 
metastasis to lung [8]. It is suggested that breast cancer spread to 
the sternum via the parasternal lymph nodes [9]. So breast cancer 
involves the spine, ribs and sternum with a high frequency. 
Although, in our study the number of lung cancer pa-
tients was low, ribs followed by spine are most frequent sites of 
bone involvement. In other studies, it has been suggested that lung 
cancers via the pulmonary veins and then arterial system involve 
appendicular skeleton more frequently than other cancers, which 
is in accordance with Ewing’s hypothesis [5]. 
Our results show that the spine, pelvis and ribs are the main 
sites of bone metastases and the extremities, especially the distal 
portions, are non-predilection sites. Of the extremities, proximal 
portions of femurs are most frequent involvement site. 
Of 58 patients with bone metastases, 75.9% had symptoms of 
bone pain. Of all patients with bone pain, 45.4% had bone metas-
tasis. Concordance between the bone pain area and metastatic 
involvement in the same region was noticed in the skull, sternum, 
pelvis, lumbar vertebrae, and proximal portion of the femurs. So, 
we have to pay more attention to the symptoms in this area which 
is more likely suggestive of bone metastasis.
Study limitations: The sample of our data for GI and lung cancer 
was not large. Therefore it is recommended to investigate more 
patients with these cancers.
Conclusions
The distributions of metastatic bone lesions in the prostate 
cancer involved mainly the pelvis and spine, while breast cancer 
showed high frequency of involvement of the spine, ribs and ster-
num. Most frequent involvement sites in lung cancer were spine 
and ribs. Our results indicate that the spine and pelvis in prostate 
carcinoma and the spine, ribs and sternum in breast carcinoma 
are frequently invaded, which in agreement with Ewing theory. On 
the other hand, distribution of bone metastases in the regions of 
the red bone marrow supports Paget’s theory. Bone pain in the 
skull, sternum, lumbar vertebrae, pelvis and proximal portion are 
more important to keep in mind for metastatic bone involvement. 
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